VIM and asthma: Multivariate analysis revealed that elevated IL-1β (5.6-fold increase in risk) and high expression of iNOS and vimentin (6.3 and 7.9-fold increase in risk) were significant risk factors for the development of comorbidity of PAR and asthma (Table 3).